We are live on !
Find out more
BLB&B Advisors Portfolio holdings
AUM
$2.78B
Turnover
8.81%
1-Year Est. Return
18.83%
BLB&B Advisors, known as BLBB, is an independent, employee-owned wealth advisory firm founded in 1964 by Frank Burke and Nick Lawton. It provides financial planning and investment management to individuals and families, nonprofits and business owners. Unlike many advisers, it does not outsource investment management. Each client gets a team with a wealth advisor, a financial planner and a client service administrator.
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+18.83%
3 Year Est. Return
+82.03%
5 Year Est. Return
+80.22%
10 Year Est. Return
+238.94%
AUM
$2.78B
AUM Growth
+$48.9M
(+1.8%)
Cap. Flow
+$22.5M
Cap. Flow % of AUM
Cap. Flow %
0.81%
Top 10 Holdings %
Top 10 Hldgs %
50.74%
Holding
295
New
9
Increased
81
Reduced
150
Closed
17
Avg Time Held
7.3
years
Top 10 Avg Time Held
5.7
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alpha Architect US Equity 4 ETF
AAUB
|
+$15.4M |
| 2 |
Micron Technology
MU
|
+$9.27M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$9.02M |
| 4 |
Vanguard Core Bond ETF
VCRB
|
+$7.52M |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
D.R. Horton
DHI
|
+$7.29M |
| 2 |
Palo Alto Networks
PANW
|
+$6.23M |
| 3 |
Microsoft
MSFT
|
+$6.01M |
| 4 |
Baker Hughes
BKR
|
+$4.75M |
| 5 |
NVIDIA
NVDA
|
+$1.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 63.55% |
| 2 | Technology | 15.01% |
| 3 | Financials | 4.7% |
| 4 | Industrials | 3.11% |
| 5 | Healthcare | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Truist Financial
TFC
$60.1B
| $265K | 0.01% |
5,730
+11
| +0.2% | +$559 |
2024 Q3
8 quarters
|
|
252
Vertex Pharmaceuticals
VRTX
$137B
| $265K | 0.01% |
506
| – | – |
2024 Q2
9 quarters
|
|
253
iShares Dow Jones US ETF
IYY
$3.01B
| $262K | 0.01% |
1,413
-107
| -7% | -$19.8K |
2024 Q1
10 quarters
|
|
254
iShares Russell Top 200 Value ETF
IWX
$3.9B
| $261K | 0.01% |
2,387
| – | – |
2025 Q2
5 quarters
|
|
255
Mondelez International
MDLZ
$79.6B
| $258K | 0.01% |
4,465
-1,212
| -21% | -$74.6K |
2013 Q2
53 quarters
|
|
256
Edwards Lifesciences
EW
$54.5B
| $256K | 0.01% |
2,966
-2,160
| -42% | -$192K |
2016 Q2
41 quarters
|
|
257
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.1B
| $247K | 0.01% |
3,198
+308
| +11% | +$24.1K |
2026 Q2
1 quarter
|
|
258
Northrop Grumman
NOC
$79.6B
| $247K | 0.01% |
510
+13
| +3% | +$7K |
2017 Q3
36 quarters
|
|
259
Colgate-Palmolive
CL
$74.1B
| $246K | 0.01% |
2,887
| – | – |
2013 Q2
53 quarters
|
|
260
iShares MSCI Emerging Markets ex China ETF
EMXC
$26B
| $241K | 0.01% |
2,429
| – | – |
2026 Q2
1 quarter
|
|
261
Vanguard Intermediate-Term Treasury ETF
VGIT
$40.2B
| $239K | 0.01% |
4,211
| – | – |
2024 Q4
7 quarters
|
|
262
Dominion Energy
D
$57.2B
| $238K | 0.01% |
3,934
-40
| -1% | -$2.69K |
2013 Q2
53 quarters
|
|
263
Capital Group Dividend Value ETF
CGDV
$40B
| $230K | 0.01% |
+4,716
| New | +$234K |
2026 Q3
0 quarters
|
|
264
Zimmer Biomet
ZBH
$18.5B
| $226K | 0.01% |
2,545
-1,057
| -29% | -$100K |
2013 Q2
53 quarters
|
|
265
SLB Ltd
SLB
$79.8B
| $226K | 0.01% |
4,630
-2,320
| -33% | -$120K |
2013 Q2
53 quarters
|
|
266
CVS Health
CVS
$115B
| $222K | 0.01% |
2,588
+162
| +7% | +$15.9K |
2026 Q2
1 quarter
|
|
267
Humana
HUM
$49.2B
| $222K | 0.01% |
581
-2
| -0.3% | -$778 |
2026 Q2
1 quarter
|
|
268
Schwab US Large- Cap ETF
SCHX
$74.3B
| $219K | 0.01% |
7,284
| – | – |
2026 Q2
1 quarter
|
|
269
Waters Corp
WAT
$46.9B
| $217K | 0.01% |
+493
| New | +$198K |
2026 Q3
0 quarters
|
|
270
Sprott Physical Gold
PHYS
$14.4B
| $215K | 0.01% |
6,883
-1,212
| -15% | -$39.1K |
2026 Q1
2 quarters
|
|
271
Booking.com
BKNG
$113B
| $213K | 0.01% |
1,309
+41
| +3% | +$7.7K |
2025 Q3
4 quarters
|
|
272
Invesco Pennsylvania Value Municipal Income Trust
VPV
$192M
| $211K | 0.01% |
20,086
| – | – |
2013 Q2
53 quarters
|
|
273
NRG Energy
NRG
$20.3B
| $207K | 0.01% |
2,167
+33
| +2% | +$3.98K |
2025 Q1
6 quarters
|
|
274
SEI Investments
SEIC
$12.4B
| $205K | 0.01% |
+2,000
| New | +$207K |
2026 Q3
0 quarters
|
|
275
Becton Dickinson
BDX
$53.8B
| $203K | 0.01% |
+1,132
| New | +$197K |
2026 Q3
0 quarters
|
|
Similar funds
BLB&B Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, BLB&B Advisors held 295 positions worth $2.78B, up 1.8% from $2.73B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
BLB&B Advisors's Q3 2026 filing shows 9 new, 81 increased, 150 reduced and 17 closed positions. Its largest new stake was Alpha Architect US Equity 4 ETF: 303,051 shares worth $15.5M. The largest sale was D.R. Horton, an estimated $7.29M.
By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, up from 63% a quarter earlier, followed by Technology and Financials.
- BLB&B Advisors's largest Q3 2026 buy was Alpha Architect US Equity 4 ETF: 303,051 shares worth $15.5M.
- BLB&B Advisors added most to Micron Technology in Q3 2026, an estimated $9.27M increase.
- BLB&B Advisors's biggest Q3 2026 reduction was D.R. Horton, cutting an estimated $7.29M.
- BLB&B Advisors fully exited iShares Ultra Short Duration Bond Active ETF in Q3 2026, selling an estimated $1.08M.
- BLB&B Advisors's ten largest holdings make up 51% of its $2.78B portfolio in Q3 2026.
- BLB&B Advisors opened 9 new positions and closed 17 in Q3 2026.
- BLB&B Advisors's portfolio value rose 1.8% quarter-over-quarter to $2.78B.
Based on BLB&B Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.